ALFA Finder| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 475.6 | 445.4 | 390.2 |
| Other income | -0.0 | 1.0 | 2.0 |
| Total income | 475.6 | 446.3 | 392.2 |
| Profit before exceptional items & tax | -28.7 | -25.2 | -45.5 |
| Exceptional items | 3.7 | -6.2 | 0.0 |
| Profit before tax | -25.0 | -31.3 | -45.5 |
| Net profit | -23.7 | -29.4 | -41.3 |
| Operating margin | -5.3% | -7.0% | -11.6% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | +21.90% |
|---|
NSE results filing, NSE: INDOCO. Figures extracted from the filing.
Indoco Remedies Ltd: key numbers
- Share price
- ₹228.32
- Market cap
- ₹2,108 Cr
- Revenue (annual)
- ₹1,845 Cr
- Net profit (annual)
- ₹-95.14 Cr
- P/E (TTM)
- 66.0×Sector 43.8×
- Promoter holding
- 58.92%+0.06% QoQ
- FII holding
- 1.64%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indoco Remedies Ltd
All →Indoco Remedies Promoter Buying: ₹0.12 Cr
Four Indoco Remedies promoters bought 5,225 shares on NSE on November 11 and 12, 2026. The purchases total about Rs.0.12 Crore, with each holding changing marginally.
- Value
- ₹0.12 Cr
Indoco Remedies Promoter Buying: ₹0.45 Cr
Four Indoco Remedies promoters bought 20,740 shares on NSE on 5 November 2026. Aggregate purchase value is about Rs.0.45 Crore.
- Value
- ₹0.45 Cr
Indoco Remedies Promoter Buying: ₹0.03 Cr
Indoco Remedies promoter and director Suresh G Kare bought 1,335 equity shares on the open market on 6 November 2026, raising holding from 1.42% to 1.42%. The trade value is Rs.2,84,248, about Rs.0.03 Crore.
- Value
- ₹0.03 Cr
Indoco Remedies Promoter Buying: ₹0.13 Cr
Indoco Remedies promoters Aditi M. Panandikar and Madhura Suresh Kare acquired a combined 5,996 equity shares via market purchase. The total transaction value is ₹0.13 Crore.
- Value
- ₹0.13 Cr
- Promoter stake change
- +0.01%
Indoco Remedies Promoter Buying: ₹0.17 Cr
Indoco Remedies' promoters Aditi Panandikar and Madhura Suresh Kare acquired 8,004 shares via market purchase. The total transaction value is ₹0.17 Crore.
- Value
- ₹0.17 Cr
Indoco Remedies Earnings Call Transcript: Key Takeaways
Indoco Remedies hit record quarterly revenue exceeding ₹500 Cr, but faced margin compression from elevated geopolitical freight and material costs.
- Call
- Guides 10% growth